GLP-1R activation leads to a rapid increase in the levels of cyclic adenosine monophosphate (AMP) and intracellular calcium followed by glucose-dependent insulin release
Alpha-adrenergic agonists: Limited (and often very small) studies of Clonidine and Guanfacine report improvements in behaviors such as hyperactivity, impulsivity, stereotypies, self-stimulation, inappropriate speech, irritability, aggression, and oppositional behavior as a frequent side effect in individuals with ASD
Further research is needed to fully understand the connection between LDN and histamine intolerance or DAO levels
The study adjusted for a number of covariates which led to no increase in the risk of aspiration pneumonia among GLP-1 RAs and did not find an increase in risk (HR=0.78
Health Eur
The FDAs approval was based on results from the Phase III CheckMate901 trial, where the combo regimen demonstrated a statistically significant improvement in overall survival and progression-free survival compared to cisplatin-gemcitabine alone, BMS reported
